` 301015 (Qingdao Baheal Medical Inc) vs Shanghai Composite Comparison - Alpha Spread

Q
301015
vs
S
Shanghai Composite

Over the past 12 months, Qingdao Baheal Medical Inc has underperformed Shanghai Composite, delivering a return of +0% compared to the Shanghai Composite's +25% growth.

Stocks Performance
301015 vs Shanghai Composite

Loading
301015
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
301015 vs Shanghai Composite

Loading
301015
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
301015 vs Shanghai Composite

Loading
301015
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Qingdao Baheal Medical Inc vs Peers

Shanghai Composite
301015
LITSD
CAH
8611
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Qingdao Baheal Medical Inc
Glance View

Market Cap
12.5B CNY
Industry
Health Care

Qingdao Baheal Medical Inc. emerged as a prominent player in China's burgeoning healthcare industry, carving a niche with its innovative approach to integrating traditional Chinese medicine with modern healthcare solutions. The company began its journey by focusing on pharmaceutical distribution, leveraging an extensive network that spans across the vast Chinese landscape. By aligning itself with both domestic and international pharmaceutical giants, Baheal Medical has ensured a steady pipeline of products that cater to the diverse needs of a growing and health-conscious population. Its core business model revolves around the distribution of pharmaceuticals and medical devices, but what sets it apart is its strategic embrace of digital technology to enhance its services. Through a sophisticated data-driven platform, Baheal Medical optimizes supply chain efficiency and ensures timely delivery of high-quality medical products, reinforcing its reputation for reliability. Apart from its distribution prowess, Baheal Medical has astutely diversified its income streams by investing heavily in healthcare innovation and research. It has established partnerships with various technology firms to develop cutting-edge health management services, thus positioning itself at the forefront of China's evolving healthcare landscape. This engagement with technology extends to personalized healthcare solutions, employing data analytics to tailor medical products and services to individual patient needs. By combining traditional pharmaceutical revenues with these innovative initiatives, Baheal Medical not only secures its profitability but also contributes significantly to the modernization and digital transformation of healthcare solutions in China. Through its forward-thinking strategies and commitment to quality, Baheal Medical continues to flourish as a beacon of healthcare excellence.

Intrinsic Value
27.13 CNY
Undervaluation 12%
Intrinsic Value
Price
Q
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett